These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6119413)
1. Formes frustes in myeloproliferative disorders. Identification by the growth of an endogenous erythroid clone in vitro in patients with arterial vascular disease. Reid CD; Chanarin I; Lewis J Lancet; 1982 Jan; 1(8262):14-5. PubMed ID: 6119413 [TBL] [Abstract][Full Text] [Related]
2. The significance of endogenous erythroid colonies (EEC) in haematological disorders. Reid CD Blood Rev; 1987 Jun; 1(2):133-40. PubMed ID: 3332094 [TBL] [Abstract][Full Text] [Related]
3. The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease. Lucas GS; Padua RA; Masters GS; Oscier DG; Jacobs A Br J Haematol; 1989 Aug; 72(4):530-3. PubMed ID: 2775657 [TBL] [Abstract][Full Text] [Related]
4. Erythroid colony formation in primary thrombocythaemia: evidence of hypersensitivity to erythropoietin. Eridani S; Batten E; Sawyer B Br J Haematol; 1984 Jan; 56(1):157-61. PubMed ID: 6704323 [TBL] [Abstract][Full Text] [Related]
5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Baxter EJ; Scott LM; Campbell PJ; East C; Fourouclas N; Swanton S; Vassiliou GS; Bench AJ; Boyd EM; Curtin N; Scott MA; Erber WN; Green AR; Lancet; 2005 Mar 19-25; 365(9464):1054-61. PubMed ID: 15781101 [TBL] [Abstract][Full Text] [Related]
6. In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders. Weinberg RS Semin Hematol; 1997 Jan; 34(1):64-9. PubMed ID: 9025164 [TBL] [Abstract][Full Text] [Related]
7. [Polycythemia: primary or secondary? The differential diagnostic value of stem cell cultures]. Küng C; Huxol H; Müller R; Speck B; Nissen C Schweiz Med Wochenschr; 1993 Jan; 123(3):53-6. PubMed ID: 8426948 [TBL] [Abstract][Full Text] [Related]
8. [Estimation of growth of erythropoietin-independent (endogenous) erythroid colonies from the bone marrow cells and peripheral blood of patients with chronic myeloproliferative diseases before and after treatment]. Manakova TE; Tsvetaeva NV; Sokolova MA; Momotiuk KS Klin Lab Diagn; 2007 Dec; (12):40-2. PubMed ID: 18225511 [No Abstract] [Full Text] [Related]
9. Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. Prchal JF; Adamson JW; Murphy S; Steinmann L; Fialkow PJ J Clin Invest; 1978 Apr; 61(4):1044-7. PubMed ID: 659576 [TBL] [Abstract][Full Text] [Related]
10. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609 [TBL] [Abstract][Full Text] [Related]
11. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Michiels JJ; Juvonen E Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Westwood NB; Pearson TC Leuk Lymphoma; 1996 Sep; 22 Suppl 1():95-103. PubMed ID: 8951779 [TBL] [Abstract][Full Text] [Related]
13. Erythropoiesis during an erythroblastic phase of chronic myeloproliferative disorder associated with monosomy 7. Kojima S; Mimaya J; Tonouchi T; Yokochi T; Kajitani S Br J Haematol; 1987 Apr; 65(4):391-4. PubMed ID: 3580297 [TBL] [Abstract][Full Text] [Related]